China SXT PharmaceuticalsSXTC 
$0.85-5.56%24h
-5.56%24h
Global rank
Market cap$480.70K
Change 7d-14.91%
YTD Performance-67.43%
SP500 benchmarkUnderperform
P/E0
P/S0.24
Revenue$1.97M
Earnings-$5.93M
Dividend yield-
Main Sector
Healthcare
Category
EPS for China SXT Pharmaceuticals (SXTC)
China SXT Pharmaceuticals has an EPS of $-137.925. In 2021, the company made an earnings per share (EPS) of $-95.475. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for SXTC
-
Value:-
EPS history for China SXT Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$137.93 | 44.46% |
| 2021 | -$95.47 | -88.53% |
| 2020 | -$832.05 | - |
View the highest EPS stocks
